The stock of Phibro Animal Health has recently consolidated the strong quarterly numbers and could now be on the verge of breaking out of the tight base!

Reading Time: 1 minute
Phibro Animal Health is a provider of animal health products and nutrition solutions aimed at optimizing animal productivity. Its product range includes feed additives and vaccines. Last year, the division of medicated feed additives was acquired from Zoetis, adding 37 new product lines. According to management, this acquisition is expected to significantly increase margins. After strong numbers for Q3 on May 7, the company raised its full-year guidance, expecting revenue between $1.26 and $1.29 billion, representing a year-on-year increase of...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.